Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Rafael Fonseca MD
Rafael Fonseca MD Editor-in-Chief
David Henry MD
David Henry MD Advisory Board
Sara Tolaney MD, MPH
Sara M. Tolaney MD, MPH Advisory Board
See All Experts
featured
Published in Oncology

Journal Scan / Research · February 21, 2019

Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma

Clinical Cancer Research

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Axel Grothey MD

Clinical Cancer Research
Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated Within the EORTC 62043/62072 Trials
Clin. Cancer Res 2019 Feb 14;[EPub Ahead of Print], O Mir, N Touati, M Lia, S Litière, A Le Cesne, S Sleijfer, JY Blay, M Leahy, R Young, RHJ Mathijssen, NP Van Erp, H Gelderblom, WT Van der Graaf, A Gronchi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated